X

retail pharmacy

CVS Earnings: CVS Health Q3 adj. profit drops despite 6% revenue growth

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) on Wednesday announced third-quarter 2024 results, reporting a decrease in adjusted earnings and…

What to look for when CVS Health (CVS) reports Q3 earnings

Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a…

Infographic: How Walgreens Boots Alliance (WBA) performed in Q4 2024

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2024 earnings results today. Sales increased 6% year-over-year to $37.5 billion.…

Walgreens Boots Alliance’s Q4 results likely to reflect market challenges

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been struggling to maintain sales momentum and profitability for quite some time due…

TRxADE Health changes its name to Scienture Holdings

Trxade Health, Inc. (NASDAQ: MEDS), a leading health services IT company, and its wholly owned subsidiary Scienture, LLC revealed that…

Trxade Health (MEDS) Q2 2024 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform with a mission to revolutionize the healthcare industry…

Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2024 results

Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Wednesday reported an increase in revenues and adjusted profit for the…

MEDS Earnings: A snapshot of Trxade’s Q2 2024 results

Health services IT company Trxade Health, Inc. (NASDAQ: MEDS) announced financial results for the second quarter of 2024, reporting a…

CVS Earnings: CVS Health Q2 adj. profit drops but beats estimates

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) on Wednesday announced second-quarter 2024 results, reporting a decrease in adjusted earnings despite…

CVS Health to report Q2 2024 results on Wednesday. Here’s what to expect

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) had a modest start to fiscal 2024, with sales and profit coming under…

Trxade Health closes business combination with Scienture in $103Mln deal

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, has announced the closing of its business combination with…

Key highlights from Walgreens Boots Alliance’s (WBA) Q3 2024 earnings results

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported third quarter 2024 earnings results today. Sales increased 2.6% year-over-year to $36.4 billion.…

WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable…

WBA Earnings: Walgreens Boots Alliance Q2 profit and sales beat estimates

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the second quarter of 2024. Net…

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on…

Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform, focused on digitalizing the retail pharmacy…

MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023.…

Walgreens Boots Alliance (WBA) Q1 2024 profit and sales beat estimates

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the first quarter of 2024. Net…

Walgreens (WBA) to report Q1 results on Thursday. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is scheduled to report first-quarter earnings on Thursday, amid expectations for a mixed outcome.…

Earnings Summary: Highlights of Catalent’s Q1 2024 results

Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for…

Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As…